• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辅助化疗后乳腺癌患者的免疫细胞图谱。

Immune cell repertoires in breast cancer patients after adjuvant chemotherapy.

机构信息

Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.

Department of Medicine, Veterans Administration Healthcare System, Palo Alto, California, USA.

出版信息

JCI Insight. 2020 Feb 27;5(4):134569. doi: 10.1172/jci.insight.134569.

DOI:10.1172/jci.insight.134569
PMID:32102986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7101137/
Abstract

Adjuvant chemotherapy in breast cancer patients causes immune cell depletion at an age when the regenerative capacity is compromised. Successful regeneration requires the recovery of both quantity and quality of immune cell subsets. Although immune cell numbers rebound within a year after treatment, it is unclear whether overall compositional diversity is recovered. We investigated the regeneration of immune cell complexity by comparing peripheral blood mononuclear cells from breast cancer patients ranging from 1-5 years after chemotherapy with those of age-matched healthy controls using mass cytometry and T cell receptor sequencing. These data reveal universal changes in patients' CD4+ T cells that persisted for years and consisted of expansion of Th17-like CD4 memory populations with incomplete recovery of CD4+ naive T cells. Conversely, CD8+ T cells fully recovered within a year. Mechanisms of T cell regeneration, however, were unbiased, as CD4+ and CD8+ T cell receptor diversity remained high. Likewise, terminal differentiated effector memory cells were not expanded, indicating that regeneration was not driven by recognition of latent viruses. These data suggest that, while CD8+ T cell immunity is successfully regenerated, the CD4 compartment may be irreversibly affected. Moreover, the bias of CD4 memory toward inflammatory effector cells may impact responses to vaccination and infection.

摘要

辅助化疗会导致乳腺癌患者的免疫细胞耗竭,而此时的再生能力已经受损。成功的再生需要恢复免疫细胞亚群的数量和质量。尽管在治疗后一年内免疫细胞数量会反弹,但尚不清楚整体组成多样性是否得到恢复。我们使用质谱流式细胞术和 T 细胞受体测序,比较了化疗后 1-5 年的乳腺癌患者和年龄匹配的健康对照者的外周血单核细胞,以此来研究免疫细胞复杂性的再生。这些数据揭示了患者 CD4+T 细胞的普遍变化,这些变化持续多年,包括 Th17 样 CD4 记忆细胞群的扩增,而 CD4+幼稚 T 细胞未能完全恢复。相反,CD8+T 细胞在一年内完全恢复。然而,T 细胞再生的机制是无偏见的,因为 CD4+和 CD8+T 细胞受体多样性仍然很高。同样,终末分化的效应记忆细胞也没有扩增,表明再生不是由潜伏病毒的识别所驱动的。这些数据表明,虽然 CD8+T 细胞免疫成功再生,但 CD4 细胞群可能受到不可逆转的影响。此外,CD4 记忆细胞向炎症效应细胞的偏向可能会影响对疫苗和感染的反应。

相似文献

1
Immune cell repertoires in breast cancer patients after adjuvant chemotherapy.辅助化疗后乳腺癌患者的免疫细胞图谱。
JCI Insight. 2020 Feb 27;5(4):134569. doi: 10.1172/jci.insight.134569.
2
Analysis of naïve and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/neu peptide (E75) and GM-CSF vaccine.对接受HER2/neu肽(E75)和GM-CSF疫苗的乳腺癌患者中初始和记忆性CD4和CD8 T细胞群体的分析。
Cancer Immunol Immunother. 2007 Feb;56(2):135-46. doi: 10.1007/s00262-006-0188-9. Epub 2006 Jun 17.
3
Clinical, immunological and treatment-related factors associated with normalised CD4+/CD8+ T-cell ratio: effect of naïve and memory T-cell subsets.与CD4+/CD8+ T细胞比值正常化相关的临床、免疫学及治疗相关因素:初始和记忆性T细胞亚群的作用
PLoS One. 2014 May 9;9(5):e97011. doi: 10.1371/journal.pone.0097011. eCollection 2014.
4
T-cell dynamics after high-dose chemotherapy in adults: elucidation of the elusive CD8+ subset reveals multiple homeostatic T-cell compartments with distinct implications for immune competence.成人高剂量化疗后的T细胞动力学:对难以捉摸的CD8 +亚群的阐释揭示了多个稳态T细胞区室,对免疫能力具有不同影响。
Immunology. 2002 May;106(1):27-37. doi: 10.1046/j.1365-2567.2002.01400.x.
5
Reference values for CD4+ and CD8+ T lymphocytes with naïve or memory phenotype and their association with mortality in the elderly.具有初始或记忆表型的CD4+和CD8+ T淋巴细胞的参考值及其与老年人死亡率的关联。
Gerontology. 2009;55(3):314-21. doi: 10.1159/000199451. Epub 2009 Feb 4.
6
Association of a Type 2-Polarized T Cell Phenotype With Methotrexate Nonresponse in Patients With Rheumatoid Arthritis.2 型极化 T 细胞表型与类风湿关节炎患者甲氨蝶呤治疗无应答的相关性。
Arthritis Rheumatol. 2020 Jul;72(7):1091-1102. doi: 10.1002/art.41223. Epub 2020 May 29.
7
Reconstitution of naïve T cells and type 1 function after autologous peripheral stem cell transplantation: impact on the relapse of original cancer.自体外周血干细胞移植后初始T细胞的重建及1型功能:对原发癌复发的影响
Transplantation. 2002 Apr 27;73(8):1336-9. doi: 10.1097/00007890-200204270-00025.
8
Naïve and central memory T-cell lymphopenia in end-stage renal disease.终末期肾病中的初始和中枢记忆性T细胞淋巴细胞减少症。
Kidney Int. 2006 Jul;70(2):371-6. doi: 10.1038/sj.ki.5001550. Epub 2006 May 31.
9
Longitudinal analysis of T-cell receptor repertoires reveals persistence of antigen-driven CD4 and CD8 T-cell clusters in systemic sclerosis.纵向分析 T 细胞受体库揭示了系统性硬化症中抗原驱动的 CD4 和 CD8 T 细胞簇的持续存在。
J Autoimmun. 2021 Feb;117:102574. doi: 10.1016/j.jaut.2020.102574. Epub 2020 Dec 8.
10
Differential effect of human herpesvirus 6A on cell division and apoptosis among naive and central and effector memory CD4+ and CD8+ T-cell subsets.人类疱疹病毒6A对初始、中枢和效应记忆CD4+及CD8+ T细胞亚群的细胞分裂和凋亡的差异作用。
J Virol. 2009 Jun;83(11):5442-50. doi: 10.1128/JVI.00106-09. Epub 2009 Mar 18.

引用本文的文献

1
Universal Fab-Fc masked cytokine prodrug platform: αPD-L1/IL-15 prodrug activates CD44 CD8 T cells in tumor-draining lymph nodes to enhance antitumor immunity.通用Fab-Fc屏蔽细胞因子前药平台:αPD-L1/IL-15前药激活肿瘤引流淋巴结中的CD44 CD8 T细胞以增强抗肿瘤免疫力。
J Immunother Cancer. 2025 Jul 31;13(7):e011944. doi: 10.1136/jitc-2025-011944.
2
Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality.三阴性乳腺癌会改变全身免疫格局并改变中性粒细胞功能。
NPJ Breast Cancer. 2025 Jan 23;11(1):5. doi: 10.1038/s41523-025-00721-2.
3
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial.新辅助纳武利尤单抗或纳武利尤单抗联合伊匹单抗治疗早期三阴性乳腺癌:一项 2 期适应性试验。
Nat Med. 2024 Nov;30(11):3223-3235. doi: 10.1038/s41591-024-03249-3. Epub 2024 Sep 16.
4
Systemic inflammation and changes in physical well-being in patients with breast cancer: a longitudinal study in community oncology settings.乳腺癌患者的全身炎症与身体状况变化:一项社区肿瘤学环境中的纵向研究。
Oncologist. 2025 Feb 6;30(2). doi: 10.1093/oncolo/oyae212.
5
Peripheral immune cells in metastatic breast cancer patients display a systemic immunosuppressed signature consistent with chronic inflammation.转移性乳腺癌患者的外周免疫细胞呈现出与慢性炎症一致的全身性免疫抑制特征。
NPJ Breast Cancer. 2024 Apr 23;10(1):30. doi: 10.1038/s41523-024-00638-2.
6
Efficacy and safety of PD-1 blockade plus long-course chemoradiotherapy in locally advanced rectal cancer (NECTAR): a multi-center phase 2 study.PD-1阻断联合长疗程放化疗治疗局部晚期直肠癌的疗效和安全性(NECTAR):一项多中心2期研究
Signal Transduct Target Ther. 2024 Mar 11;9(1):56. doi: 10.1038/s41392-024-01762-y.
7
Circulating Leukocyte Subsets Before and After a Breast Cancer Diagnosis and Therapy.循环白细胞亚群在乳腺癌诊断和治疗前后的变化。
JAMA Netw Open. 2024 Feb 5;7(2):e2356113. doi: 10.1001/jamanetworkopen.2023.56113.
8
MDR1-EXPRESSING CD4 T CELLS WITH TH1.17 FEATURES RESIST TO NEOADJUVANT CHEMOTHERAPY AND ARE ASSOCIATED WITH BREAST CANCER CLINICAL RESPONSE.表达 MDR1 的 CD4 T 细胞具有 TH1.17 特征,对新辅助化疗有耐药性,并与乳腺癌临床反应相关。
J Immunother Cancer. 2023 Nov;11(11). doi: 10.1136/jitc-2023-007733.
9
A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer.帕博利珠单抗联合紫杉醇或固定剂量卡培他滨用于一线/二线转移性三阴性乳腺癌的Ib期试验。
NPJ Breast Cancer. 2023 Jun 21;9(1):53. doi: 10.1038/s41523-023-00541-2.
10
Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Where Are We Now and Where Are We Headed?早期三阴性乳腺癌的免疫治疗:我们现在在哪里,我们的目标在哪里?
Curr Treat Options Oncol. 2023 Aug;24(8):1004-1020. doi: 10.1007/s11864-023-01087-y. Epub 2023 May 24.

本文引用的文献

1
Differential Cytokine Utilization and Tissue Tropism Results in Distinct Repopulation Kinetics of Naïve vs. Memory T Cells in Mice.差异细胞因子利用和组织嗜性导致小鼠中幼稚 T 细胞与记忆 T 细胞的再群体动力学明显不同。
Front Immunol. 2019 Mar 4;10:355. doi: 10.3389/fimmu.2019.00355. eCollection 2019.
2
Activation of miR-21-Regulated Pathways in Immune Aging Selects against Signatures Characteristic of Memory T Cells.miR-21 调控的免疫衰老相关通路的激活选择对抗记忆 T 细胞特征性特征。
Cell Rep. 2018 Nov 20;25(8):2148-2162.e5. doi: 10.1016/j.celrep.2018.10.074.
3
Human retinoic acid-regulated CD161 regulatory T cells support wound repair in intestinal mucosa.人维甲酸调控的 CD161+调节性 T 细胞支持肠道黏膜的伤口修复。
Nat Immunol. 2018 Dec;19(12):1403-1414. doi: 10.1038/s41590-018-0230-z. Epub 2018 Nov 5.
4
Opinion: Virtual memory CD8 T cells and lymphopenia-induced memory CD8 T cells represent a single subset: Homeostatic memory T cells.观点:虚拟记忆 CD8 T 细胞和淋巴细胞减少诱导的记忆 CD8 T 细胞代表一个单一的亚群:稳态记忆 T 细胞。
Immunol Lett. 2018 Nov;203:57-61. doi: 10.1016/j.imlet.2018.09.003. Epub 2018 Sep 20.
5
Clinical significance of CD161+CD4+ T cells in the development of chronic antibody-mediated rejection in kidney transplant recipients.CD161+CD4+T 细胞在肾移植受者慢性抗体介导排斥反应发展中的临床意义。
PLoS One. 2018 Jul 16;13(7):e0200631. doi: 10.1371/journal.pone.0200631. eCollection 2018.
6
Age-Related Decline in Primary CD8 T Cell Responses Is Associated with the Development of Senescence in Virtual Memory CD8 T Cells.与虚拟记忆 CD8 T 细胞衰老相关的原发性 CD8 T 细胞反应的年龄相关性下降。
Cell Rep. 2018 Jun 19;23(12):3512-3524. doi: 10.1016/j.celrep.2018.05.057.
7
Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome.LLT1及其受体CD161在肺癌中的表达与更好的临床结局相关。
Oncoimmunology. 2018 Jan 29;7(5):e1423184. doi: 10.1080/2162402X.2017.1423184. eCollection 2018.
8
Identity and Diversity of Human Peripheral Th and T Regulatory Cells Defined by Single-Cell Mass Cytometry.通过单细胞质谱流式细胞术定义的人类外周辅助性T细胞和调节性T细胞的特征与多样性
J Immunol. 2018 Jan 1;200(1):336-346. doi: 10.4049/jimmunol.1701025. Epub 2017 Nov 27.
9
A pathology atlas of the human cancer transcriptome.人类癌症转录组病理学图谱。
Science. 2017 Aug 18;357(6352). doi: 10.1126/science.aan2507.
10
Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy.急性髓系白血病患者化疗后B细胞免疫受损。
J Transl Med. 2017 Jul 10;15(1):155. doi: 10.1186/s12967-017-1252-2.